Deep-pocketed investors have adopted a bearish approach towards Cigna CI, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CI usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 21 extraordinary options activities for Cigna. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 23% leaning bullish and 33% bearish. Among these notable options, 8 are puts, totaling $415,286, and 13 are calls, amounting to $601,365.
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $250.0 to $290.0 for Cigna during the past quarter.
Volume & Open Interest Trends
In terms of liquidity and interest, the mean open interest for Cigna options trades today is 453.83 with a total volume of 8,228.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Cigna's big money trades within a strike price range of $250.0 to $290.0 over the last 30 days.
Cigna Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CI | PUT | SWEEP | BULLISH | 01/16/26 | $32.3 | $32.0 | $32.0 | $280.00 | $115.2K | 871 | 555 |
| CI | CALL | SWEEP | NEUTRAL | 01/16/26 | $38.3 | $37.7 | $37.99 | $280.00 | $89.1K | 110 | 267 |
| CI | PUT | SWEEP | BULLISH | 01/16/26 | $32.9 | $32.7 | $32.7 | $280.00 | $85.1K | 871 | 243 |
| CI | CALL | TRADE | NEUTRAL | 01/16/26 | $39.5 | $37.8 | $38.79 | $280.00 | $77.5K | 110 | 299 |
| CI | PUT | TRADE | NEUTRAL | 01/16/26 | $34.7 | $31.2 | $32.83 | $280.00 | $65.6K | 871 | 285 |
About Cigna
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.
After a thorough review of the options trading surrounding Cigna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Where Is Cigna Standing Right Now?
- Currently trading with a volume of 826,260, the CI's price is down by -1.63%, now at $279.95.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 14 days.
What The Experts Say On Cigna
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $390.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * Maintaining their stance, an analyst from Truist Securities continues to hold a Buy rating for Cigna, targeting a price of $390.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Cigna, Benzinga Pro gives you real-time options trades alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
